{"id":"W2154948351","doi":"10.1200/jco.2003.06.099","title":"Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vinorelbine; Medicine; Gemcitabine; Internal medicine; Lung cancer; Cisplatin; Hazard ratio; Oncology; Chemotherapy; Cancer; Ototoxicity; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00212019,0.001295168,0.00221752,0.0004125935,0.0002934808,0.001050256,0.0009295727,0.001536775,0.003657879],"category_scores_gemma":[0.002012408,0.0005803748,0.001964754,0.0004173353,0.0007772912,0.0005992428,0.0004062949,0.002388184,0.0004700164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001109528,"about_ca_system_score_gemma":0.001158396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001389347,"about_ca_topic_score_gemma":0.003324088,"domain_scores_codex":[0.9993069,0.0004383096,0.00003635085,0.00008752292,0.00005198356,0.0000790295],"domain_scores_gemma":[0.9990595,0.000327351,0.0002301829,0.00006801788,0.000043197,0.0002716838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9743112,0.006485203,0.0006504215,0.0003688862,0.0008594694,0.00002250508,0.00003582038,0.0004707999,0.001644416,0.00007313889,0.0005804247,0.01449766],"study_design_scores_gemma":[0.9042305,0.09112633,0.002508495,0.00003468036,0.0004787255,0.00002980007,0.00001446571,0.000583261,0.00035496,0.00008494961,0.0005428047,0.0000111166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913728,0.003357928,0.0002904758,0.0005122903,0.0003397939,0.002069179,0.0004275704,0.00005445552,0.001575507],"genre_scores_gemma":[0.9900972,0.002349664,0.0009781693,0.0006363445,0.0003523483,0.002185239,0.0008072963,0.00001455602,0.002579286],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003657879,"threshold_uncertainty_score":0.01223683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.134450896684909,"score_gpt":0.4988893839233714,"score_spread":0.3644384872384624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}